Literature DB >> 2967812

Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus.

M Venditti, A Micozzi, P Serra, G Buniva, L Palma, P Martino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2967812     DOI： 10.1093/jac/21.4.513

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics of teicoplanin.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1990-03       Impact factor: 6.447

Review 2.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

3.  Treatment of cerebrospinal fluid shunt infections with teicoplanin.

Authors:  M L Fernández Guerrero; M de Górgolas; R Fernández Roblas; J M Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.